February 22, 2016 by Brian Bossetta and Chain Drug Review
Alan Lotvin, CVS Health, CVS Health Research Institute, CVS/specialty, Specialty Connect, specialty pharmacy, William Shrank
2016, Issue 02-22-2016, Issues, News
WOONSOCKET, R.I. — New research published by the CVS Health Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health’s specialty prescription services program. New patients enrolled in the pilot were 17.5% more likely to pick up their first refill, and existing
January 29, 2016 by Chain Drug Review
Alan Lotvin, CVS Health, CVS Health Research Institute, CVS Specialty, Specialty Connect, specialty drug, specialty pharmacy, William Shrank
Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — CVS Health found that patients in a pilot study of its Specialty Connect specialty drug program had a significant improvement in adherence to their medication. CVS said Friday that new patients enrolled in the pilot were 17.5% more likely to pick up their first refill, and current specialty patients had an 11.4
November 18, 2015 by Chain Drug Review
Brian Tilzer, CVS Health, CVS Health Digital Innovation Lab, digital health, MedRemind, William Shrank
Leading Headlines, Pharmacy, Retail News, Technology

WOONSOCKET, R.I. — CVS Health has unveiled a suite of digital tools designed to help customers better manage and adhere to their prescriptions. The company said Wednesday that the five new digital health tools — Apple Watch app integration, Scan Paper Script, Insurance Card Scan, MedRemind and in-store pharmacy messages — were developed to address
October 26, 2015 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, CVS Health, Jeffrey Woldt, medication adherence, MinuteClinic, Pharmacy Advisor, Predictive Adherence Index, retail pharmacy, ScriptSync, Vulnerable Patient Index, William Shrank
2015, Issue 10-26-2015, Issues, Leading Headlines, Opinion

The move toward closer cooperation among providers is one of the more intriguing developments in health care, one that promises to improve patient outcomes and limit expenditures in a sector that accounts for almost 20% of the nation’s gross domestic product. The rationale behind the partnerships, and the role of community pharmacies within them, is
September 28, 2015 by Mark Baumgartner and Chain Drug Review
CVS Health, CVS Health Research Institute, medication adherence, narrow pharmacy networks, William Shrank
2015, Issue 09-28-2015, Issues, News
WOONSOCKET, R.I. — A CVS Health Research Institute review of pharmacy claims for more than 200,000 patients found an association between narrow pharmacy networks and improved medication adherence. The study was the first to evaluate the impact of narrow pharmacy networks — which incentivize plan members to use in-network pharmacies — on medication adherence. Such
September 21, 2015 by Chain Drug Review
Brigham and Women's Hospital, CVS Health, CVS Health Research Institute, medication adherence, Niteesh Choudhry, William Shrank
Featured Articles, Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — The first prescriptions filled by patients with chronic conditions provide a good sign of how well they will adhere to their medications, according to research by CVS Health. CVS said Monday that a new study by the CVS Health Research Institute and Brigham and Women’s Hospital revealed that patients’ patterns of medication
September 8, 2015 by Chain Drug Review
CVS Health, CVS Health Research Institute, CVS/caremark, drug benefit plans, medication adherence, narrow pharmacy networks, preferred pharmacies, prescription drug coverage, William Shrank
Featured Articles, Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — Members of drug benefit plans with narrow pharmacy networks show improved medication adherence, according to a new study by the CVS Health Research Institute. CVS Health said Tuesday that the research, published in JAMA Internal Medicine, is the first to gauge the impact of narrow pharmacy networks on medication adherence. Narrow networks
August 22, 2015 by Scot Meyer and Chain Drug Review
cholesterol management guidelines, cholesterol-lowering medications, CVS Health, CVS Health Research Institute, PCSK9 inhibitors, Troyen Brennan, William Shrank
2015, Issue 08-24-2015, Issues, News
WOONSOCKET, R.I. — CVS Health Research Institute experts have urged cardiologists to consider changing their treatment guidelines for patients with high cholesterol as a new class of high-cost medications arrives on the market. A commentary published online in the Journal of the American Medical Association on August 10 argued that the new cholesterol-lowering drugs, known
August 18, 2015 by Chain Drug Review
Andrew Sussman, CVS Health, Journal of General Internal Medicine, MinuteClinic, retail clinic, telehealth, William Shrank
Featured Articles, Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — Retail clinic patients find the telehealth experience very satisfying, according to a CVS Health Research Institute study of a pilot program at MinuteClinic. CVS said Tuesday that satisfaction with quality of care and other factors were measured among patients participating in a telehealth technology pilot conducted at MinuteClinic locations in California and
August 10, 2015 by Chain Drug Review
American College of Cardiology/American Heart Association, CVS Health Research Institute, Journal of the American Medical Association, management of high cholesterol, PCSK9 inhibitors, Praluent, Troy Brennan, William Shrank
Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — The cardiology community should review and reconsider current treatment guidelines for the management of high cholesterol, according to experts at the CVS Health Research Institute. In a commentary published online Monday in the Journal of the American Medical Association (JAMA), the CVS Health experts said that as PCSK9 inhibitors — a new